Chongqing, China

Dahai Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Nhwaluokang Pharmceutical Research and Development Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dahai Chen. Retrieved from https://idiyas.com/inventor/dahai-chen-ap4atlmo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dahai Chen: Innovator in Water-Soluble Taxane Derivatives

Introduction

Dahai Chen is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of water-soluble taxane derivatives. His innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Dahai Chen holds a patent for "Water-soluble taxane derivatives and uses thereof." This invention discloses a class of water-soluble taxane derivatives, along with methods for treating tumors using these compounds. The derivatives serve as anti-tumor drugs and can be utilized in the preparation of such drugs. The general formula for these derivatives includes various chemical components, allowing for a range of applications in oncology.

Career Highlights

Throughout his career, Dahai Chen has worked with reputable organizations, including Jiangsu Nhwaluokang Pharmaceutical Research and Development Co., Ltd. His experience in pharmaceutical research and development has been instrumental in advancing his innovative ideas.

Collaborations

Dahai Chen has collaborated with notable colleagues such as Qingeng Li and Tao Wang. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Dahai Chen's contributions to the field of pharmaceuticals, particularly through his patent on water-soluble taxane derivatives, highlight his role as an innovator. His work not only showcases his expertise but also holds promise for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…